Non-fluent Aphasia
10
2
2
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.4% vs benchmark
10%
1 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 6 completed trials
Clinical Trials (10)
Combined Intervention Program for Non-fluent Aphasia Based on Neuroplasticity
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
Combining tDCS and CILT in Non-fluent Aphasia
Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech
Home-Based Exercise in Primary Progressive Aphasia (HEPPA)
High-frequency nrTMS on the Contralateral Broca Mirror Area for Glioma Patients With Early Postoperative Aphasia
Neural Networks and Language Recovery in Aphasia From Stroke: fMRI Studies
Transcranial Direct Current Stimulation and Aphasia Language Therapy
PiB PET Scanning in Speech and Language Based Dementias
Augmenting Language Therapy for Aphasia: Levodopa